Skip to content
Home
About us
Careers
Investors
Corporate governance
Shareholder information
Investor tools
Directors' shareholdings
SEC filings
Events calendar
Financial results
Annual reports
Presentations & webcasts
-
2008
-
2007
-
2006
-
2005
-
2004
-
2003
-
2002
-
2001
-
2000
-
1999
Financial highlights
Strategy
FAQs
Investor contacts
Media
Partnering
Products
Research
Responsibility
Contact us
Home
Investors
Presentations & webcasts
1999
1999 Presentations
1999 annual results presentation to analysts (24 February 2000)
Slide presentation - 462 kb
1999 pharmaceutical R&D presentation to analysts (6 December 1999)
CNS - Ron Polinsky - 303 kb
Cardiovascular - Hamish Cameron - 672 kb
Discovery - Jan M Lundberg - 618 kb
Gastrointestinal - Martin Nicklasson - 328 kb
Infection - Aileen Allsop - 135 kb
Oncology - Brent Vose - 613 kb
Pain - Carl-Johan Dalsgaard - 313 kb
Respiratory - Colin Reddrop - 613 kb
Strategy - Claes Wilhelmsson - 502 kb
Conclusion - Tom McKillop - 132 kb
1999 half year results presentation to analysts (26 July 1999)
Slide presentation - 260 kb
AstraZeneca websites
Search
Advanced search
Quick links
Key products
R&D pipeline
Visit Dow Jones (external link)
Visit FTSE4Good (external link)
Site map
Order a report
Online order form
Tel: +44 (0)1707 256 677
Share price
London
22.25
GBP
New York
43.52
USD
Stockholm
260.50
SEK
Updated 16:02 GMT 16 May 08
Downloads
Acrobat® PDF Reader (external link)
Terms of use
Privacy policy
© AstraZeneca PLC 2003 - 2008